Susceptibility patterns of coagulase-negative staphylococci to several newer antimicrobial agents in comparison with vancomycin and oxacillin

Richards, 1999, Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System, Crit Care Med, 27, 887, 10.1097/00003246-199905000-00020 Schwalbe, 1987, Emergence of vancomycin resistance in coagulase-negative staphylococci, N Engl J Med, 316, 927, 10.1056/NEJM198704093161507 Behme, 1996, Identification of staphylococci with a self-educating system using fatty acid analysis and biochemical tests, J Clin Microbiol, 34, 3075, 10.1128/JCM.34.12.3075-3084.1996 Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. Document M7-A7. Wayne, PA: CLSI; 2006. Hussain, 2000, Correlation of oxacillin MIC with mecA gene carriage in coagulase-negative staphylococci, J Clin Microbiol, 38, 752, 10.1128/JCM.38.2.752-754.2000 Veach, 1990, Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection, J Clin Microbiol, 28, 2064, 10.1128/JCM.28.9.2064-2068.1990 Silverman, 2003, Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus, Antimicrob Agents Chemother, 47, 2538, 10.1128/AAC.47.8.2538-2544.2003 Critchley, 2003, Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000–2001, J Antimicrob Chemother, 51, 639, 10.1093/jac/dkg130 Johnson, 2004, Calcium-supplemented daptomycin Etest strips for susceptibility testing on Iso-Sensitest agar, J Antimicrob Chemother, 53, 860, 10.1093/jac/dkh198 Attwood, 2007, Telavancin: a novel lipoglycopeptide antimicrobial agent, Am J Health Syst Pharm, 64, 2335, 10.2146/ajhp070080 Wong, 1999, Bacteremia caused by staphylococci with inducible vancomycin heteroresistance, Clin Infect Dis, 29, 760, 10.1086/520429 Mendes, 2010, Activity of telavancin and comparator antimicrobial agents tested against Staphylococcus spp. isolated from hospitalised patients in Europe (2007–2008), Int J Antimicrob Agents, 36, 374, 10.1016/j.ijantimicag.2010.05.016 Gander, 2005, Telavancin: in vitro activity against staphylococci in a biofilm model, J Antimicrob Chemother, 56, 337, 10.1093/jac/dki198 Farrell, 2009, Linezolid surveillance program results for 2008 (LEADER Program for 2008), Diagn Microbiol Infect Dis, 65, 392, 10.1016/j.diagmicrobio.2009.10.011 Gales, 2008, Tigecycline activity tested against 11808 bacterial pathogens recently collected from US medical centers, Diagn Microbiol Infect Dis, 60, 421, 10.1016/j.diagmicrobio.2007.10.017